Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Part D Rebates Linger As Possible Cost Offset Option In MedPAC's Medicare "Doc Fix"

This article was originally published in The Pink Sheet Daily

Executive Summary

Recommendation for physician sustainable growth rate repeal, including list of possible cost offsets, will be sent to Congress later this month.

You may also be interested in...



MedPAC Finalizes 2013 Medicare Pay Rate Recommendations

One percent update for inpatient services, cap of outpatient “evaluation and management” services to physician rates supported by influential congressional advisory group.

MedPAC's Permanent "Doc Fix" For Medicare Seeks $75 Bil. Offset From Drug Firms

The Medicare Payment Advisory Commission's draft plan seeks approximately $235 billion in offsets from a range of non-physician sources.

Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind

Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS072982

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel